Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
CNY 5.52
(-0.18%)
CNY 5.52
(-0.18%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 449.76 Million CNY | -36.29% |
| 2022 | 705.97 Million CNY | 25.16% |
| 2021 | 564.05 Million CNY | 19.63% |
| 2020 | 471.51 Million CNY | -8.47% |
| 2019 | 515.14 Million CNY | -21.33% |
| 2018 | 654.8 Million CNY | 13.69% |
| 2017 | 575.97 Million CNY | 7.98% |
| 2016 | 533.39 Million CNY | -21.75% |
| 2015 | 681.67 Million CNY | 26.95% |
| 2014 | 536.97 Million CNY | 56.26% |
| 2013 | 343.63 Million CNY | 8.31% |
| 2012 | 317.27 Million CNY | 25.86% |
| 2011 | 252.08 Million CNY | 35.8% |
| 2010 | 185.62 Million CNY | 29.57% |
| 2009 | 143.26 Million CNY | 38.01% |
| 2008 | 103.8 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 91.35 Million CNY | -0.49% |
| 2024 Q3 | 93.46 Million CNY | 2.31% |
| 2024 Q1 | 91.8 Million CNY | -22.54% |
| 2023 Q1 | 108.15 Million CNY | -34.06% |
| 2023 Q4 | 118.51 Million CNY | 4.71% |
| 2023 FY | 449.76 Million CNY | -36.29% |
| 2023 Q3 | 113.18 Million CNY | -4.73% |
| 2023 Q2 | 118.8 Million CNY | 9.85% |
| 2022 FY | 705.97 Million CNY | 25.16% |
| 2022 Q3 | 167.67 Million CNY | -8.22% |
| 2022 Q4 | 164.02 Million CNY | -2.18% |
| 2022 Q1 | 191.57 Million CNY | 27.93% |
| 2022 Q2 | 182.7 Million CNY | -4.63% |
| 2021 Q4 | 149.75 Million CNY | -11.28% |
| 2021 Q1 | 115.72 Million CNY | -21.13% |
| 2021 Q2 | 129.79 Million CNY | 12.16% |
| 2021 Q3 | 168.78 Million CNY | 30.05% |
| 2021 FY | 564.05 Million CNY | 19.63% |
| 2020 FY | 471.51 Million CNY | -8.47% |
| 2020 Q4 | 146.72 Million CNY | -1.3% |
| 2020 Q3 | 148.65 Million CNY | 23.57% |
| 2020 Q2 | 120.3 Million CNY | 115.47% |
| 2020 Q1 | 55.83 Million CNY | -63.59% |
| 2019 FY | 515.14 Million CNY | -21.33% |
| 2019 Q4 | 153.32 Million CNY | 39.06% |
| 2019 Q3 | 110.25 Million CNY | -18.18% |
| 2019 Q2 | 134.74 Million CNY | 15.35% |
| 2019 Q1 | 116.81 Million CNY | -10.99% |
| 2018 Q2 | 171.4 Million CNY | -0.1% |
| 2018 Q1 | 171.56 Million CNY | -8.26% |
| 2018 Q3 | 180.6 Million CNY | 5.37% |
| 2018 FY | 654.8 Million CNY | 13.69% |
| 2018 Q4 | 131.23 Million CNY | -27.34% |
| 2017 Q2 | 142.81 Million CNY | 26.14% |
| 2017 Q4 | 187 Million CNY | 40.66% |
| 2017 FY | 575.97 Million CNY | 7.98% |
| 2017 Q1 | 113.21 Million CNY | -23.88% |
| 2017 Q3 | 132.94 Million CNY | -6.91% |
| 2016 Q2 | 131.82 Million CNY | 5.27% |
| 2016 Q3 | 127.59 Million CNY | -3.21% |
| 2016 Q4 | 148.73 Million CNY | 16.57% |
| 2016 FY | 533.39 Million CNY | -21.75% |
| 2016 Q1 | 125.23 Million CNY | -46.4% |
| 2015 Q2 | 152.45 Million CNY | 3.73% |
| 2015 Q4 | 233.63 Million CNY | 57.21% |
| 2015 FY | 681.67 Million CNY | 26.95% |
| 2015 Q3 | 148.61 Million CNY | -2.52% |
| 2015 Q1 | 146.97 Million CNY | -37.16% |
| 2014 FY | 536.97 Million CNY | 56.26% |
| 2014 Q4 | 233.87 Million CNY | 116.19% |
| 2014 Q3 | 108.17 Million CNY | -8.41% |
| 2014 Q2 | 118.1 Million CNY | 53.77% |
| 2014 Q1 | 76.81 Million CNY | 9.32% |
| 2013 Q3 | 97.88 Million CNY | 0.59% |
| 2013 FY | 343.63 Million CNY | 8.31% |
| 2013 Q2 | 97.3 Million CNY | 24.47% |
| 2013 Q4 | 70.26 Million CNY | -28.22% |
| 2013 Q1 | 78.17 Million CNY | -15.4% |
| 2012 Q1 | 64.58 Million CNY | -14.77% |
| 2012 Q2 | 76.92 Million CNY | 19.11% |
| 2012 FY | 317.27 Million CNY | 25.86% |
| 2012 Q3 | 83.34 Million CNY | 8.35% |
| 2012 Q4 | 92.4 Million CNY | 10.87% |
| 2011 Q1 | 48.7 Million CNY | 0.0% |
| 2011 Q3 | 63.53 Million CNY | -0.85% |
| 2011 Q2 | 64.07 Million CNY | 31.56% |
| 2011 FY | 252.08 Million CNY | 35.8% |
| 2011 Q4 | 75.77 Million CNY | 19.27% |
| 2010 FY | 185.62 Million CNY | 29.57% |
| 2009 FY | 143.26 Million CNY | 38.01% |
| 2008 FY | 103.8 Million CNY | 0.0% |